Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why Pradaxa is not a bad drug

John Mandrola, MD
Meds
May 23, 2012
Share
Tweet
Share

It’s crazy out there in blood thinner land.

The novel blood thinning drug for patients with atrial fibrillation, dabigatran (Pradaxa) cannot get a break.

It’s all over the TV: Pradaxa = Bad drug.

Look at this image:

On the prestigious heart news site, theheart.org, an insignificant 113-patient study presented as a poster at a small symposium — by a researcher with ties to anti-coagulation clinics — gets attention because a few patients on dabigatran developed well-known complications. Though the author makes important points, namely, that blood-thinners should be used cautiously and patients should be well-informed about the risks and benefits, the study added nothing to what is already known about dabigatran.

Gosh. I can’t believe I feel a twinge of empathy for a Big Pharma company.

Here’s a news flash.

Dabigatran and rivaroxaban are blood thinners. They lower the risk of stroke, but increase the risk of bleeding. It’s the same for warfarin. When these two agents were compared to warfarin in huge randomized controlled clinical trials, they both looked favorable.

For my entire career, I have heard the downsides of warfarin. Now, we have two drugs that prevent more strokes than warfarin, don’t require blood checks, have no dietary interactions, minimal drug-drug interactions and are not used to poison rats. Do they worsen bleeding when one falls? Yes. So does warfarin.

Folks, of course it is better to not have a disease that increases the risk of stroke. That’s what I have been saying since I started this blog. Prevention is better. Go to bed on time, exercise every day that you eat, eat less, drink fewer irritants, don’t sweat getting a B+ and smile at your neighbor. I know; these are hard therapies with which to adhere.

But blood thinners are not bad medicines. They are medicines. They have risks and they have benefits. And the alternative: a patient can have the disease and its inherent risks.

John Mandrola is a cardiologist who blogs at Dr John M.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

A good doctor should rarely be surprised by test results

May 23, 2012 Kevin 5
…
Next

Patients are our best teachers

May 23, 2012 Kevin 1
…

Tagged as: Medications

Post navigation

< Previous Post
A good doctor should rarely be surprised by test results
Next Post >
Patients are our best teachers

ADVERTISEMENT

More by John Mandrola, MD

  • What we can learn about weight loss from Al Sharpton

    John Mandrola, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Don’t be foolish enough to think you control outcomes

    John Mandrola, MD
  • a desk with keyboard and ipad with the kevinmd logo

    The problem with Obamacare is that it doesn’t do enough

    John Mandrola, MD

More in Meds

  • The economics of medical weight loss

    Howard Smith, MD
  • Why the cannabis ethics debate is really about human suffering

    Gerald Kuo
  • Testosterone cardiovascular risk: FDA update 2025

    Martina Ambardjieva, MD, PhD
  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician leadership communication tips

      Imamu Tomlinson, MD, MBA | Physician
    • Why senior-friendly health materials are essential for access

      Gerald Kuo | Conditions
    • Why developmental and behavioral pediatrics faces a recruitment collapse

      Ronald L. Lindsay, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 17 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician leadership communication tips

      Imamu Tomlinson, MD, MBA | Physician
    • Why senior-friendly health materials are essential for access

      Gerald Kuo | Conditions
    • Why developmental and behavioral pediatrics faces a recruitment collapse

      Ronald L. Lindsay, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Why Pradaxa is not a bad drug
17 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...